Christopher Patusky is Director at UNITED THERAPEUTICS CORP (UTHR). They have made 20 open-market trades across 1 company since 2006, most recently 2026-07-09.
CIK 0001231427
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2017, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 2,140 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-07-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-04-24 | 2026-04-24 | $569.00 | $1.7M | +5.2% | +2.0% | -6.7% |
| UTHR | SELL · 10b5-1 | 2026-04-17 | 2026-04-17 | $578.88 | $579K | -3.8% | -4.5% | -10.9% |
| UTHR | SELL | 2025-12-15 | 2025-12-16 | $495.95 | $496K | +0.6% | -5.6% | +6.8% |
| UTHR | SELL · 10b5-1 | 2025-03-19 | 2025-03-20 | $310.78 | $3.0M | -1.4% | -8.7% | -6.3% |
| UTHR | SELL · 10b5-1 | 2025-01-10 | 2025-01-13 | $361.80 | $3.3M | +2.4% | +2.4% | -21.5% |
| UTHR | SELL | 2024-09-03 | 2024-09-05 | $354.33 | $1.8M | -1.4% | +0.0% | +7.0% |
| UTHR | SELL | 2024-06-17 | 2024-06-18 | $295.50 | $591K | +4.3% | +7.5% | +12.8% |
| UTHR | SELL | 2024-05-14 | 2024-05-15 | $264.35 | $693K | -1.3% | +5.6% | +18.7% |
| UTHR | SELL | 2024-02-23 | 2024-02-26 | $224.00 | $376K | +7.2% | +8.6% | +20.2% |
| UTHR | SELL · 10b5-1 | 2022-11-17 | 2022-11-18 | $262.61 | $26K | +4.0% | +2.5% | -5.1% |
| UTHR | SELL | 2021-11-08 | 2021-11-08 | $200.16 | $460K | +1.0% | -3.3% | -0.4% |
| UTHR | SELL · 10b5-1 | 2021-05-10 | 2021-05-10 | $190.52 | $19K | +2.6% | -6.2% | +11.5% |
| UTHR | SELL | 2019-03-07 | 2019-03-08 | $110.75 | $746K | +9.5% | +2.9% | -26.8% |
| UTHR | SELL | 2017-10-20 | 2023-05-03 | $111.37 | $2K | -2.4% | -1.1% | +9.3% |
| UTHR | BUY | 2017-07-17 | 2023-05-03 | $115.35 | $2K | -2.4% | -1.1% | +9.3% |
| UTHR | SELL | 2017-01-12 | 2017-01-12 | $141.99 | $710K | +6.6% | +11.5% | -17.3% |
| UTHR | SELL | 2016-11-10 | 2016-11-14 | $131.37 | $1.2M | +1.2% | +3.8% | +23.7% |
| UTHR | SELL | 2016-09-01 | 2016-09-02 | $122.73 | $614K | -0.3% | -3.9% | +3.1% |
| UTHR | SELL · 10b5-1 | 2015-03-05 | 2015-03-06 | $161.36 | $807K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-02-27 | 2015-02-27 | $155.05 | $1.2M | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2015-01-08 | 2015-01-12 | $128.13 | $641K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2014-12-04 | 2014-12-04 | $129.05 | $645K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2014-11-07 | 2014-11-07 | $124.49 | $622K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2014-08-07 | 2014-08-11 | $88.23 | $441K | -11.9% | +0.8% | +0.8% |
| UTHR | SELL · 10b5-1 | 2014-05-08 | 2014-05-09 | $107.17 | $536K | -11.9% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.